Myeloproliferative neoplasm with ETV6-ABL1 fusion: A case report and literature review

Molecular Cytogenetics

Volumn 6, Issue 1, 2013, Pages

  Gancheva, Katya ^a   Virchis, Andres ^b   Howard Reeves, Julie ^c   Cross, Nick Cp ^d   Brazma, Diana ^c   Grace, Colin ^a   Kotzampaltiris, Paul ^c   Partheniou, Fedra ^c   Nacheva, Elisabeth ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b BARNET HOSPITAL   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Atypical CML; ETV6 ABL1; Nilotinib; Resistance to imatinib

Indexed keywords

BCR ABL PROTEIN; IMATINIB; MESSENGER RNA; NILOTINIB; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR ETV6 ABL1 PROTEIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW; CASE REPORT; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARYOTYPE; MYELOPROLIFERATIVE NEOPLASM; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84884336369     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-6-39     Document Type: Article

References (31)

1. A chronic myeloid leukemia case with a unique variant Philadelphia translocation: t(9;22;21)(q34;q11;p12). Al-Achkar W, Oncol Lett 2012 3 5 1027 1029 Epub 2012 Feb 28 22783385
2. ABL1 fusion genes in hematological malignancies: a review. De-Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, Férec C, De-Braekeleer M, Eur J Haematol 2011 86 361 371 10.1111/j.1600-0609.2011.01586.x 21435002
3. The novel activation of ABL by fusion to an ets-related gene, TEL. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM, Cancer Res 1995 55 34 38 7805037
4. Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin. Zuna J, Zaliova M, Muzikova K, Meyer C, Lizcova L, Zemanova Z, Brezinova J, Votava F, Marschalek R, Stary J, Trka J, Genes Chromosomes Cancer 2010 49 873 884 10.1002/gcc.20796 20589932
5. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia. Zhou M-H, Gao L, Jing Y, Xu Y-Y, Ding Y, Wang N, Wang W, Li M-Y, Han X-P, Sun J-Z, Wang L-L, Yu L, Ann Hematol 2012 91 1235 1243 10.1007/s00277-012- 1431-4 22373549
6. A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia. Malone A, Langabeer S, O'Marcaigh A, Storey L, Bacon CL, Smith OP, Br J Haematol 2010 151 101 102 10.1111/j.1365-2141.2010.08323.x 20618334
7. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Mol Cell Biol 1996 16 4107 4116 8754809
8. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia. Brunel V, Sainty D, Costello R, Mozziconacci M-J, Simonetti J, Arnoulet C, Coignet L, Bouabdallah R, Gastaut JA, Gabert J, Cancer Genet Cytogenet 1995 85 82 84 10.1016/0165-4608(95)00140-9 8536245
9. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Höglund M, Genes Chromosomes Cancer 1997 20 299 304 10.1002/(SICI)1098- 2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K 9365838
10. Molecular cytogenetic and clinical findings in ETV6/ABL1positive leukemia. Van-Limbergen H, Beverloo HB, van-Drunen E, Janssens A, Hählen K, Poppe B, Van-Roy N, Marynen P, De-Paepe A, Slater R, Genes Chromosomes Cancer 2001 30 274 282 10.1002/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1 11170285
11. Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t (9;12) translocation. O'Brien SG, Blood 2002 99 3465 3467 10.1182/blood.V99.9.3465 11964320
12. Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patient. Lin H, Guo JQ, Andreeff M, Arlinghaus RB, Leukemia 2002 16 294 10.1038/sj.leu.2402353 11840298
13. Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature. Keung YK, Beaty M, Steward W, Jackle B, Pettnati M, Cancer Genet Cytogenet 2002 138 139 142 10.1016/S0165-4608(02)00609-X 12505259
14. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. La-Starza RR, Trubia MM, Testoni NN, Ottaviani EE, Belloni EE, Crescenzi BB, Martelli MM, Flandrin GG, Pelicci PGP, Mecucci CC, Haematologica 2002 87 789 794 12161353
15. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. Barbouti A, Ahlgren T, Johansson B, Hoglund M, Lassen C, Turesson I, Mitelman F, Fioretos T, Br J Haematol 2003 122 85 93 10.1046/j.1365-2141.2003.04391.x 12823349
16. Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion. Tirado C, Sebastian S, Moore J, Gong J, Goodman B, Cancer Genet Cytogenet 2005 157 74 77 10.1016/j.cancergencyto.2004.06.001 15676152
17. Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript. Meyer-Monard S, Mühlematter D, Streit A, Chase AJ, Gratwohl A, Cross NCP, Jotterand M, Tichelli A, Leukemia 2005 19 1096 1099 10.1038/sj.leu.2403697 15789067
18. A fifteen-year cytogenetic remission following interferon treatment in a patient with an indolent ETV6-ABL positive myeloproliferative syndrome. Mozziconacci M-J, Sainty D, Chabannon C, Am J Hematol 2007 82 688 689
19. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement. Baeumler J, Szuhai K, Falkenburg JHF, van-Schie MLJ, Ottmann OG, Nijmeijer BA, Cancer Genet Cytogenet 2008 185 37 42 10.1016/j.cancergencyto.2008.05.001 18656692
20. Chronic phase of ETV6-ABL1positive CML responds to imatinib. Kawamata N, Dashti A, Lu D, Miller B, Koeffler HP, Schreck R, Moore S, Ogawa S, Genes Chromosomes Cancer 2008 47 919 921 10.1002/gcc.20593 18615681
21. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: Efficacy of second-generation tyrosine kinase inhibitors. Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E, Leuk Res 2009 33 1144 1146 10.1016/j.leukres.2009.03.011 19394693
22. Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia. Kelly JC, Shahbazi N, Scheerle J, Jahn J, Suchen S, Christacos NC, Mowrey PN, Witt MH, Hostetter A, Meloni-Ehrig AM, Cancer Genet Cytogenet 2009 192 36 39 10.1016/j.cancergencyto.2009.02.012 19480935
23. Variant of ETV6/ABL1 gene is associated with leukemia phenotype. Park J, Kim M, Lim J, Kim Y, Han K, Kim JS, Lee S, Kim H-J, Min WS, Acta Haematol 2013 129 78 82 10.1159/000342490 23171811
24. ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition. Perna F, Abdel-Wahab O, Jhanwar SC, Imada K, Nimer SD, Haematol 2011 96 342 343 10.3324/haematol.2010. 036673
25. Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα Malinge S, Monni R, Bernard O, Penard-Lacronique V, Oncogene 2006 25 3589 3597 10.1038/sj.onc.1209390 16434962
26. A Direct Binding Site for Grb2 Contributes to Transformation and Leukemogenesis by the Tel-Abl (ETV6-Abl) Tyrosine Kinase. Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van-Etten RA, Mol Cell Biol 2004 24 4685 4695 10.1128/MCB.24.11.4685-4695.2004 15143164
27. An Optimized Multiplex Polymerase Chain Reaction (PCR) for Detection of BCR-ABL Fusion mRNAs in Haematological Disorders. Cross NC, Melo JV, Feng L, Goldman JM, Leukemia 1994 8 186 189 8289486
28. Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia. Nacheva EP, Brazma D, Virgili A, Howard-Reeves J, Chanalaris A, Gancheva K, Apostolova M, Valgañon M, Mazzullo H, Grace C, BMC Genomics 2010 11 41 10.1186/1471-2164-11-41 20082691
29. ARG tyrosine kinase activity is inhibited by STI571. Okuda K, Blood 2001 97 2440 2448 10.1182/blood.V97.8.2440 11290609
30. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Million RP, Blood 2002 99 4568 4577 10.1182/blood-2001-12-0244 12036890
31. Haemopoietic transformation by the TEL/ABL oncogene. Hannemann JRJ, McManus DMD, Kabarowski JHJ, Wiedemann LML, Br J Haematol 1998 102 475 485 10.1046/j.1365-2141.1998.00803.x 9695962